A case of nonalcoholic steatohepatitis and small intestinal bacterial overgrowth with peripheral edema caused by intestinal bypass surgery and relieved by repair

Gut and Liver

Volumn 6, Issue 4, 2012, Pages 520-523

  Sung, Young Kyung ^a   Gwak, Geum Youn ^a   Choi, Moon Seok ^a   Koh, Kwang Chul ^a   Paik, Seung Woon ^a   Yoo, Byung Chul ^a   Lee, Joon Hyeok ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Bypass surgery; Nonalcoholic steatohepatitis; Small intestinal bacterial overgrowth

Indexed keywords

ALBUMIN; AMINOTRANSFERASE; AMOXICILLIN; CLAVULANIC ACID; FENOVERINE; LOPERAMIDE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIAL OVERGROWTH; BARIUM ENEMA; BLOATING; CASE REPORT; COLONOSCOPY; COLOSTOMY; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN TISSUE; HYPOALBUMINEMIA; IRRITABLE COLON; JEJUNOILEAL BYPASS; LABORATORY TEST; LIVER BIOPSY; LIVER FIBROSIS; MALABSORPTION; MALE; MEDICAL HISTORY; NONALCOHOLIC FATTY LIVER; PERIPHERAL EDEMA; PHYSICAL EXAMINATION; SMALL INTESTINE; TREATMENT OUTCOME;

EID: 84868142464     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2012.6.4.520     Document Type: Article

References (26)

1. Allard JP. Other disease associations with non-alcoholic fatty liver disease (NAFLD). Best Pract Res Clin Gastroenterol 2002;16:783-795.
2. Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med 1997;126:137-145.
3. Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 2010;53:372-384.
4. Adams LA, Talwalkar JA. Diagnostic evaluation of nonalcoholic fatty liver disease. J Clin Gastroenterol 2006;40 Suppl 1:S34-S38.
5. Vuppalanchi R, Chalasani N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management. Hepatology 2009;49:306-317.
6. Tessier DJ, Eagon JC. Surgical management of morbid obesity. Curr Probl Surg 2008;45:68-137.
7. Deleña SA, Fechner RE, Brown H, Shelton EL Jr. Reversible fatty liver with fibrosis following jejunocolic shunt. South Med J 1970;63:399-402.
8. Ong JP, Younossi ZM. Epidemiology and natural history of NAFLD and NASH. Clin Liver Dis 2007;11:1-16.
9. Drenick EJ, Ament ME, Finegold SM, Corrodi P, Passaro E. Bypass enteropathy. Intestinal and systemic manifestations following small-bowel bypass. JAMA 1976;236:269-272.
10. Drenick EJ, Ament ME, Finegold SM, Passaro E Jr. Bypass enteropathy: an inflammatory process in the excluded segment with systemic complications. Am J Clin Nutr 1977;30:76-89.
11. McGill DB, Humpherys SR, Baggenstoss AH, Dickson ER. Cirrhosis and death after jejunoileal shunt. Gastroenterology 1972;63:872-877.
12. Reynolds TB. Medical complications of intestinal bypass surgery. Adv Intern Med 1978;23:47-59.
13. Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH, Cummins AG. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 2001;48:206-211.
14. Sajjad A, Mottershead M, Syn WK, Jones R, Smith S, Nwokolo CU. Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2005;22:291-299.
15. Farrell GC. Is bacterial ash the flash that ignites NASH? Gut 2001;48:148-149.
16. Wu WC, Zhao W, Li S. Small intestinal bacteria overgrowth decreases small intestinal motility in the NASH rats. World J Gastroenterol 2008;14:313-317.
17. Gasbarrini A, Lauritano EC, Gabrielli M, et al. Small intestinal bacterial overgrowth: diagnosis and treatment. Dig Dis 2007;25:237-240.
18. Singh VV, Toskes PP. Small bowel bacterial overgrowth: presentation, diagnosis, and treatment. Curr Gastroenterol Rep 2003;5:365-372.
19. Quigley EM, Abu-Shanab A. Small intestinal bacterial overgrowth. Infect Dis Clin North Am 2010;24:943-959.
20. Fan X, Sellin JH. Review article. Small intestinal bacterial overgrowth, bile acid malabsorption and gluten intolerance as possible causes of chronic watery diarrhoea. Aliment Pharmacol Ther 2009;29:1069-1077.
21. Bures J, Cyrany J, Kohoutova D, et al. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol 2010;16:2978-2990.
22. Umar SB, DiBaise JK. Protein-losing enteropathy: case illustrations and clinical review. Am J Gastroenterol 2010;105:43-49.
23. Su J, Smith MB, Rerknimitr R, Morrow D. Small intestine bacterial overgrowth presenting as protein-losing enteropathy. Dig Dis Sci 1998;43:679-681.
24. Kerckhoffs AP, Visser MR, Samsom M, et al. Critical evaluation of diagnosing bacterial overgrowth in the proximal small intestine. J Clin Gastroenterol 2008;42:1095-1102.
25. Simrén M, Stotzer PO. Use and abuse of hydrogen breath tests. Gut 2006;55:297-303.
26. Chiu NT, Lee BF, Hwang SJ, Chang JM, Liu GC, Yu HS. Protein-losing enteropathy: diagnosis with (99m)Tc-labeled human serum albumin scintigraphy. Radiology 2001;219:86-90.